The authors injected BT-474 cells into nude mice fed with a diet enriched with 4% Flaxseed oil (FSO) for four weeks, and combined this diet with Trastuzumab, an antibody specifically directed against the overexpressed HER2/neu receptor, and currently used in the therapy of human breast cancer positive for this receptor. Here, ERBB2 is linked to breast cancer.